Come up with a name for your new list and we'll add to it:
Aleva Neurotherapeutics raised a round of funding on September 10, 2015. Investors include
The Michael J. Fox Foundation.
Aleva Neurotherapeutics develops next-generation implants for Deep Brain Stimulation (DBS) therapy that are designed to be versatile, more precise and efficient than currently available DBS approaches…